Accendra Health Extends $150 Million Receivables Sale Program to 2029
Accendra Health (ACH) has officially amended its receivables sale program, extending the facility's scheduled termination date to October 2029. Despite the extension of the timeline, the total size of the program remains fixed at $150 million. The announcement coincided with significant positive momentum for the company's stock, which saw a premarket increase of nearly 21%, reaching a price of $0.31. This move provides the company with extended liquidity management capabilities through the end of the decade.
Topics: facility extension receivables sale program stock price movement